What is follicular lymphoma?

Follicular lymphoma (FL) is a type of blood cancer. It is a type of non-Hodgkin lymphoma.

It develops when blood cells called lymphocytes become abnormal. These blood cells normally help fight infection. The abnormal lymphocytes usually build up in lymph nodes, but they can affect other parts of the body.

Booklets and resources

Symptoms of follicular lymphoma

One of the most common symptoms is a painless swelling in the neck, armpit or at the top of the legs (groin). This is caused by lymphoma cells building up in the lymph nodes.

Sometimes lymphoma cells may build up in the bone marrow, where blood cells are made. This can cause:

  • anaemia – this is caused by a low number of red blood cells in the blood
  • bruising or bleeding easily – this is caused by a low number of blood-clotting cells (platelets) in the blood.

B symptoms

Follicular lymphoma may also cause the following symptoms:

  • drenching night sweats
  • unexplained weight loss.

These are called B symptoms. Along with staging and grading (below), B symptoms can help your cancer team understand:

  • how the lymphoma might develop
  • which treatments might help.

Worried about symptoms?

A change in how you feel or how your body works can be caused by conditions other than follicular lymphoma. But always ask your GP to check any ongoing, new or unexplained symptoms.

We are also here if you need someone to talk to. You can:

Related pages

Causes of follicular lymphoma

The causes of follicular lymphoma are mostly unknown. Like other cancers, it is not infectious. You cannot spread it to other people.

We have more general information about causes and risk factors of non-Hodgkin lymphoma.

Diagnosis of follicular lymphoma

If you have symptoms that worry you, you should begin by going to your GP. They may arrange for you to have blood tests or scans. If they think cancer may be causing your symptoms, they will refer you to a hospital for more tests and specialist advice and treatment.

At the hospital, a doctor will ask about any symptoms, your general health and any illnesses you have had. They will also examine you. The most important test for diagnosing FL is a biopsy. This means testing a small piece of tissue or a sample of cells from an area of the body affected.

Find out more about having a biopsy and other tests in our general lymphoma information.

Waiting for test results

Waiting for test results can be a difficult time. It may take up to 2 weeks for the results to be ready.

You may find it helpful to talk to family members or a close friend. Your specialist nurse can also provide support.

You can talk to one of our cancer support specialists for free on 0808 808 0000, 7 days a week, 8am to 8pm.

Booklets and resources

Staging and grading of follicular lymphoma

Your test results give your cancer team more information about the lymphoma. This includes:

  • The stage

    Staging describes how many areas of the body are affected by lymphoma and where these areas are.

  • The grade

    Grading describes how quickly the lymphoma cells are likely to grow. Follicular lymphoma is a low grade lymphoma. This means it usually develops slowly. Sometimes it can change (transform) into a high grade lymphoma. High grade lymphoma grows more quickly and needs urgent treatment.

Knowing the stage and grade of the lymphoma helps your cancer team plan the right treatment for you.

We have more information about staging and grading non-Hodgkin lymphoma.

Treatment for follicular lymphoma

A team of specialists will meet to discuss the best possible treatment for you. They are called a multidisciplinary team (MDT).

After the MDT meeting, you will usually meet with your cancer doctor and specialist nurse. They will explain the different treatments and their side effects. They will also talk to you about things to consider when making treatment decisions.

Treatment for follicular lymphoma depends on the stage of the lymphoma and whether you have symptoms that are causing problems. It can often be kept under control with treatment.

You may have some treatments as part of a clinical trial.

Watch and wait

Follicular lymphoma usually develops slowly. If you have no symptoms, you may not need any treatment. You may not need treatment for many years. Some people never need treatment.

Instead of having treatment straight away, you may have regular tests and appointments to monitor the lymphoma. This is called watch and wait. It may also be called active surveillance or active monitoring. Doctors will check for signs that you need to start treatment. Watch and wait is a way of safely delaying treatment until you need it.

First line treatment

The first treatment you have is called first line treatment. The aim of treatment is to make all signs of the lymphoma disappear. This is called remission. These are the most common treatments for follicular lymphoma.

  • Cancer drug treatment

    Follicular lymphoma is often treated with cancer drugs. You may have an immunotherapy drug on its own. Or you may have immunotherapy with a combination of chemotherapy drugs and sometimes also steroids. The main immunotherapy drugs used are:

    The most common combinations of chemotherapy are:

    • CVP – called R-CVP (with rituximab) or O-CVP (with obintuzumab)
    • CHOP – called R-CHOP (with rituximab) or O-CHOP (with obintuzumab)
    • bendamustine with rituximab.
  • Radiotherapy

    Radiotherapy uses high-energy rays called radiation to treat cancer. It destroys cancer cells in the area you have it..

    Follicular lymphoma is usually very sensitive to radiotherapy. You might have radiotherapy as your first treatment if the lymphoma only affects 1 or 2 groups of lymph nodes in the same part of the body. This is stage 1 or 2 lymphoma.

Maintenance treatment

If the lymphoma is in remission after first line treatment, your cancer team may talk to you about having maintenance treatment. This means ongoing treatment to help stop the lymphoma coming back for as long as possible. You will have rituximab or obinutuzumab, usually once every 8 weeks for up to 2 years.

Treating follicular lymphoma relapse

First line treatment is often very effective. It may make all signs of follicular lymphoma disappear for a time. Some people will not need further treatment for many years. But follicular lymphoma usually comes back. This is called recurrence or relapse.

You can usually have more treatment to help control it again. It may be possible to get the lymphoma into a second remission.

Treatments that can be used include:

  • the same combination of cancer drugs you had the first time – if you had a long period in remission
  • a different combination of cancer drugs
  • an immunotherapy drug on its own
  • a drug called lenalidomide
  • intensive treatment with a stem cell transplant.

Your cancer team will discuss the best options for your situation.

Radiotherapy can also be used to treat lymphoma that has come back in one group of lymph nodes. Radiotherapy is also sometimes given to treat symptoms, such as pain.

Treating transformed follicular lymphoma

Sometimes follicular lymphoma can change from low grade into high grade lymphoma. This is called transformation or transformed follicular lymphoma. Your cancer team will do tests to check for this when you are diagnosed or have a recurrence of follicular lymphoma.

High grade lymphoma grows more quickly. It is treated differently. Transformed follicular lymphoma is treated in the same way as another type of lymphoma called DLBCL.

After follicular lymphoma treatment

Follow-up after treatment for follicular lymphoma

You will have regular check-ups during and after your follicular lymphoma treatment. Your cancer doctor or specialist nurse will explain what to expect.

Follow-up appointments are a good time for you to talk to your cancer doctor or specialist nurse about any concerns you have. Tell them as soon as possible if you have any problems or notice new symptoms between appointments. We have more information about follow-up care after treatment.

Sometimes side effects may continue or develop months or years after treatment. These are called late effects. We have more information about late effects of lymphoma treatment.

Wellbeing and recovery

Looking after yourself can help speed up your recovery after follicular lymphoma treatment. Even small lifestyle changes may improve your wellbeing and long term health.

Even if you already have a healthy lifestyle, you may choose to make some positive changes after treatment. We have more information on leading a healthy lifestyle after treatment.

Support for people with follicular lymphoma

People often have many different feelings during and after follicular lymphoma treatment. If you have finished treatment, you may feel relieved it has ended but worried about what might happen in the future.

It is important to know where to get support or information if you need it. People often need support even some time after follicular lymphoma treatment. But sometimes it is difficult to know who to ask for help.

You can:

You may also find the HOPE programme helpful. The programme is a free 6 week self-management course designed to help you develop techniques and strategies when living with or after cancer. Topics include goal setting, fatigue management, and wellbeing.

You can sign up for the online HOPE programme. Or to find out more about face to face programmes in your area, email ServiceOpsSupport@macmillan.org.uk

Other organisations who offer information and support

  • Blood Cancer UK offers support and information to people affected by blood cancers, including lymphoma.
  • Lymphoma Action provides high quality information and support for people affected by lymphoma. It provides helpline services and a range of peer support including online support meetings, educational events and webinars. Its website includes TrialsLink, a database of lymphoma clinical trials.

More information and advice

We know cancer can affect you physically, emotionally and financially. We have information and advice about different ways cancer might impact you, such as help with:

About our information

This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.

  • References

    Below is a sample of the sources used in our lymphoma information. If you would like more information about the sources we use, please contact us at informationproductionteam@macmillan.org.uk

     

    Cwynarski K, Marzolini MAV, Barrington SF, et al. The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper. Br J Haematol. 2019;185:402-9.

     

    Eyre TA, Bishton MJ, McCulloch R, et al. Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. Br J Haematol. 2024;204(1):108–26.

     

    Ferreri AJM, Illerhaus G, Doorduijn K, et al., on behalf of the EHA and ESMO Guidelines Committees. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(6):491-507.

     

    Fox CP, Ahearne MJ, Pettengell R, et al. Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline. Br J Haematol. 2022;196:507-22.

     

    Fox CP, Chaganti S, McIlroy G, et al. The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline. Br J Haematol. 2024;204(4):1178–92.

     

    McNamara C, Montoto S, Eyre TA, et al. The investigation and management of follicular lymphoma. Br J Haematol. 2020;191:363-81.

     

    Pratt G, El-Sharkawi D, Kothari J, et al. Diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline. Br J Haematol. 2022;197:171–87.

     

    Walewska R, Eyre TA, Barrington S, et al. Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline. Br J Haematol. 2024;204(1):86–107.

Date reviewed

Reviewed: 01 February 2025
|
Next review: 01 February 2028
Trusted Information Creator - Patient Information Forum
Trusted Information Creator - Patient Information Forum

Our cancer information meets the PIF TICK quality mark.

This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.

The language we use


We want everyone affected by cancer to feel our information is written for them.


We want our information to be as clear as possible. To do this, we try to:

  • use plain English
  • explain medical words
  • use short sentences
  • use illustrations to explain text
  • structure the information clearly
  • make sure important points are clear.

We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.


You can read more about how we produce our information here.